Uptake of COVID-19 vaccination in a medium secure psychiatric hospital populationForensic Published on 2021-07-012022-10-28 Journal: BJPsych Open [Category] COVID-19, [키워드] analysed Asian black collected Comorbidity complications Consent and capacity coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine declined demographics Eligible patients English Epidemiology forensic mental health services General population hospital in-patient In-patient treatment increased risk Infection medium Patient patients proportion Psychiatric refusal secure the vaccine uptake white [DOI] 10.1192/bjo.2021.924 PMC 바로가기 [Article Type] Forensic
High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic EventsArticle Published on 2021-07-012022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] activating anti-PF4 antibodies antibody antibody production Antibody Response AZD1222 baseline ChAdOx1 ChAdOx1 nCoV-19 Clinical characteristics Clinical data clinically COVID-19 elicit evaluate first dose IgG antibody induce multifactorial no correlation offer pathophysiology patients presence of antibody Prospective Study provoke recipient SARS-CoV-2 the vaccine thrombosis thrombotic event vaccinated individual Vaccine [DOI] 10.3390/vaccines9070712 PMC 바로가기 [Article Type] Article
Methodological Analysis: Randomized Controlled Trials for Pfizer and Moderna COVID-19 Vaccines방법론적 분석: Pfizer 및 Moderna COVID-19 백신에 대한 무작위 대조 시험Article Published on 2021-07-012022-09-11 Journal: Journal of pediatric health care : official public [Category] SARS, 임상, [키워드] Analysis appraisal Cambridge Care Casp CASP critical appraisals checklist checklist Community conducted Controlled coronavirus COVID-19 COVID-19 disease critical appraisal determine develop distribution Efficacy Health Health care item methodology Moderna morbidity and mortality MOST New York outcome Pfizer Population populations positive question Randomized randomized control trial Randomized controlled trial Randomized controlled trials RCT RCTs reduce Reporting reporting guidelines. rigor rigorous analysis scored skill Standard the vaccine Vaccinations Vaccine Vaccine hesitancy [DOI] 10.1016/j.pedhc.2021.04.001 PMC 바로가기 [Article Type] Article
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccinationCOVID-19 백신 접종 후 노르웨이 의료 종사자의 혈소판 감소증 및 항-PF4/다음이온 항체의 유병률을 확인하기 위한 관찰 연구Observational Study Published on 2021-07-012022-09-11 Journal: Journal of thrombosis and haemostasis : JTH [Category] SARS, 임상, 치료기술, [키워드] activating adverse effects Adverse reactions antibody Antibody testing AstraZeneca AZD1222 clinical trials Cohort Combination COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines COVID-19 vaccines/adverse effects drug related side effects and adverse reactions Effect European country European Medicines Agency first dose Health care Health care worker hospital identify immune Immunity immunoassay individual introduced knowledge majority Norway optical optical density Perceived risk Platelet platelet factor 4 presenting Prevalence recruited referred to Registered reported SARS-CoV-2 screened side Side effect study participant Study participants subject the vaccine thrombocytopenia thrombosis thrombotic Thrombotic thrombocytopenia vaccination Vaccine [DOI] 10.1111/jth.15352 PMC 바로가기 [Article Type] Observational Study
Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New VariantsMedical Technology Published on 2021-06-302022-11-01 Journal: Frontiers in Medical Technology [Category] COVID-19, [키워드] ACE2 alteration Analysis Angiotensin-converting enzyme antibody production B-cell B.1.351 binding affinity carried cellular receptor Combination conformational state conformational states contribute coronavirus COVID-19 pandemic disease dose Efficiency electrostatic interactions epitope Epitopes explain Hospitalization Increased Infection Interaction mapped molecular mechanism Mutation mutations New protein–protein interactions raising RBD RBD-ACE2 released responsible S trimer SARS-CoV-2 South spike Spread stability state Structure the receptor-binding domain the SARS-CoV-2 the vaccine Therapeutic molecule therapeutic option Transmissibility trimeric variant variants variants of SARS-CoV-2 virulence virulent virus wild type [DOI] 10.3389/fmedt.2021.694347 PMC 바로가기 [Article Type] Medical Technology
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccineNVX-CoV2373 Covid-19 백신의 안전성 및 효능Clinical Trial Published on 2021-06-302022-09-25 Journal: The New England Journal of Medicine [Category] MERS, SARS, 변종, 신약개발, 임상, 진단, [키워드] 1:1 95% CI 95% confidence interval acute respiratory syndrome Administered age Alpha Analysis assigned B.1.1.7 B.1.1.7 variant baseline Clinical data conducted coronavirus death dose Efficacy efficacy end point EudraCT full-length spike glycoprotein generally mild healthy Hospitalization illnesses immune response incidence Infection injection intramuscular Matrix-M Mild moderate Novavax NVX-CoV2373 NVX-CoV2373 vaccine observer-blinded Older participant Participants per-protocol Phase 3 Placebo placebo-controlled trial randomization Randomized receive reported Result robust Safe Safety SARS-CoV-2 SARS-COV-2 infection Serious Adverse Event Serologically Severe infection severe SARS-CoV-2 symptom onset the placebo group the vaccine two groups two-dose regimen United Kingdom Vaccine variant variants [DOI] 10.1056/NEJMoa2107659 PMC 바로가기 [Article Type] Clinical Trial
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents미국 요양원 거주자들 사이에서 mRNA SARS-CoV-2 백신 접종 후 부작용Article Published on 2021-06-292022-09-11 Journal: Vaccine [Category] SARS, 치료기술, [키워드] Adverse adverse event anaphylaxis association Comparator group COVID-19 dose EHR EHR data Electronic health record Emergency use authorization event events excluded first dose genesis health record MONITOR mRNA mRNA vaccine mRNA vaccines neurologic nursing home outcomes pandemic Prevent problem Record SARS-CoV-2 SARS-CoV-2 mRNA vaccines SARS-CoV-2 pandemic SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Skilled nursing facilities study cohort the SARS-CoV-2 The United States the vaccine Trial United States vaccination Vaccinations Vaccine Vaccine safety monitoring. [DOI] 10.1016/j.vaccine.2021.05.088 PMC 바로가기 [Article Type] Article
Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant womenPerspectives Published on 2021-06-282022-10-28 Journal: Acta Diabetologica [Category] COVID-19, MERS, SARS, [키워드] affected Breastfeeding COVID COVID-19 COVID-19 infection COVID-19 vaccination develop diabete diabetes Diabetic diabetics disease Efficacy Evidence feasibility fetal Health Organization Healthcare professional high risk Hospitalization Humoral immunity immune transfer Infection intensive care International lactating lactating women lactation morbidity mRNA mRNA vaccination National Neonatal Newborn obese obesity outcome Patient Perspective potential benefit Pregnancy pregnant pregnant women promote Prospective Study reactogenicity Result risk robust SARS-CoV-2 Symptom tested the vaccine Trigger vaccination vaccination against COVID-19 Vaccine with COVID-19 women [DOI] 10.1007/s00592-021-01764-0 PMC 바로가기 [Article Type] Perspectives
Real-World Acceptance of COVID-19 Vaccines among Healthcare Workers in Perinatal Medicine in ChinaArticle Published on 2021-06-272022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptance appear China Chinese Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 vaccination COVID-19 vaccine declined General population HCW HCWs healthcare worker Healthcare workers identify investigated Medicine National participant participated Perinatal promote questionnaire reported survey the vaccine vaccination Vaccine Vaccine acceptance Vaccine hesitancy worker [DOI] 10.3390/vaccines9070704 PMC 바로가기 [Article Type] Article
Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil브라질의 코로나 박 백신에서 P1 변이체에 의한 2 개의 예방 접종 후 SARS-COV-2 감염의 사례 연구Case Reports Published on 2021-06-262022-09-01 Journal: Viruses [Category] MERS, SARS, 변종, 임상, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Brazil Breakthrough infection breakthrough infections CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 diagnose Efficacy effort Emergency use highlight immunization immunization program Infection observation Patient potential risk Prevent raised reduced respiratory Safe SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus severity subsequent the disease the vaccine Transmission vaccination Vaccine Vaccines variant [DOI] 10.3390/v13071237 PMC 바로가기 [Article Type] Case Reports